Strictly for hospital use (Intravenous infusion): 🩸 Multiple Myeloma: Considered a cornerstone therapy for this condition. Advanced Ovarian Adenocarcinoma. Childhood Neuroblastoma. Used in regional arterial perfusion for localized malignant melanoma or soft tissue sarcoma of the extremities.

Dosage and administration

Form: Lyophilized Powder for Injection (50 mg vial). ⚠️ ADMINISTRATION WARNING: IV Only: Must be reconstituted and administered as a slow intravenous infusion. Dosing: Highly variable depending on the protocol (Standard vs. High-Dose Conditioning). Determined by Body Surface Area (BSA). Monitoring: Blood counts (CBC) must be checked frequently before each dose.

Pregnancy and breastfeeding (Teratogenic). Severe bone marrow suppression (prior to treatment start). Hypersensitivity to Melphalan.

Being a cytotoxic agent, side effects are significant: 📉 Bone Marrow Suppression: Leukopenia (low white blood cells) and Thrombocytopenia (low platelets) are the dose-limiting toxicities. Gastrointestinal: Nausea, vomiting, diarrhea, and stomatitis. Alopecia: Hair loss is common with high doses.

100% original product

Active ingredient

Melphalan

Manufacturer

Emcure

Dosage 50 mg

Dosage form Vial

Vials per pack 1

Megval (Melphalan) 50 mg

Name: Megval
Brand: Emcure
SKU: PROD-88
Price: 2857 UAH
Availability: InStock

2857₴ ~~3296₴~~ -13%

Megval-50 (Melphalan 50 mg) is a potent cytotoxic chemotherapy drug classified as an alkylating agent.

Manufacturer: Emcure Pharmaceuticals. A cost-effective injectable generic equivalent to Alkeran.

Mechanism of Action:

Melphalan works by damaging the DNA of cancer cells, preventing them from multiplying. It is historically one of the most effective drugs for treating plasma cell cancers.

✅ Key Use: Often used in "High-Dose" conditioning regimens prior to Hematopoietic Stem Cell Transplantation (HSCT).

Strictly for hospital use (Intravenous infusion):

🩸 Multiple Myeloma: Considered a cornerstone therapy for this condition.
Advanced Ovarian Adenocarcinoma.
Childhood Neuroblastoma.
Used in regional arterial perfusion for localized malignant melanoma or soft tissue sarcoma of the extremities.

Form: Lyophilized Powder for Injection (50 mg vial).

⚠️ ADMINISTRATION WARNING:

IV Only: Must be reconstituted and administered as a slow intravenous infusion.
Dosing: Highly variable depending on the protocol (Standard vs. High-Dose Conditioning). Determined by Body Surface Area (BSA).
Monitoring: Blood counts (CBC) must be checked frequently before each dose.

Pregnancy and breastfeeding (Teratogenic).
Severe bone marrow suppression (prior to treatment start).
Hypersensitivity to Melphalan.

Being a cytotoxic agent, side effects are significant:

📉 Bone Marrow Suppression: Leukopenia (low white blood cells) and Thrombocytopenia (low platelets) are the dose-limiting toxicities.
Gastrointestinal: Nausea, vomiting, diarrhea, and stomatitis.
Alopecia: Hair loss is common with high doses.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 04.03.2026

Active ingredient

Melphalan

Manufacturer

Emcure

Dosage 50 mg

Dosage form Vial

Vials per pack 1

100% original product

Delivery across Ukraine

Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Megval (Melphalan) 50 mg

What Customers Say

No reviews yet

Contact us

Request a call